Editor's Choice - The Impact of Endovascular Aneurysm Repair on Long Term Renal Function Based on Hard Renal Outcomes.


Journal

European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
ISSN: 1532-2165
Titre abrégé: Eur J Vasc Endovasc Surg
Pays: England
ID NLM: 9512728

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 11 10 2018
revised: 14 03 2019
accepted: 20 03 2019
pubmed: 23 7 2019
medline: 3 4 2020
entrez: 23 7 2019
Statut: ppublish

Résumé

Over the short term endovascular aneurysm repair (EVAR) is associated with superior outcomes compared with open repair; however, the progression of renal function after EVAR remains unknown because of the use of inconsistent reporting measures. The aim was to define long term renal decline following elective EVAR using estimated glomerular filtration rate (eGFR). The prospectively maintained in house database was used to identify consecutive patients having elective EVAR who had been followed up for more than five years. Overall, 275 patients (23 females, 8%; mean age, 75 years) who were not previously on renal replacement therapy (RRT) were included (January 2000 to July 2010). Pre-operative, post-operative, and most recent eGFR values were evaluated using the chronic kidney disease epidemiology collaboration equation. The primary outcome was change in eGFR at latest follow up. Patients were followed up over a median of 9 years (range 5-17 years). Their mean eGFR dropped from a pre-operative value of 67 mL/min/1.73 m This analysis, with some of the longest available follow up to date, suggests that patients undergoing EVAR may experience a significant long term decrease in renal function. This needs to be taken into account when offering EVAR in younger patients; renal follow up and preservation should be optimised in this patient group.

Identifiants

pubmed: 31327538
pii: S1078-5884(19)30204-7
doi: 10.1016/j.ejvs.2019.03.024
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

328-333

Informations de copyright

Copyright © 2019. Published by Elsevier B.V.

Auteurs

Edmund R Charles (ER)

Leicester Vascular Institute and National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, Leicester, UK.

Dennis Lui (D)

Leicester Vascular Institute and National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, Leicester, UK.

Jonathan Delf (J)

Leicester Vascular Institute and National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, Leicester, UK.

Robert D Sayers (RD)

Leicester Vascular Institute and National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, Leicester, UK.

Matthew J Bown (MJ)

Leicester Vascular Institute and National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, Leicester, UK.

David Sidloff (D)

Leicester Vascular Institute and National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, Leicester, UK.

Athanasios Saratzis (A)

Leicester Vascular Institute and National Institute for Health Research (NIHR) Leicester Biomedical Research Centre, Leicester, UK. Electronic address: as875@le.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH